Ergocalciferol improves endothelial function and overcomes the detrimental effect of uraemia on the endothelium in a pre clinical model of mild CKD, independently of effects of blood pressure, calcium, phosphate or parathyroid hormone. The gene discussed is PTH; the disease is chronic kidney disease.